EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Synopsys, Inc. (S1NP34) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Synopsys, Inc. BRL 32.48, price BRL 63.78, upside -49.1%, quality 29 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Technology · BR · Home US

SI Some data Sep 29, 2026

Synopsys, Inc.

S1NP34 · SA

Weakest SetupQuality growthStrongly overvalued and low quality.

!Fair value R$32.48 · Strongly overvalued (−49.1%)
!Quality 29/100
!Expensive Growth (revenue 3y +15.2 %/yr)
!Thin margins · 8.9% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers (3/10)
!Narrow moat 40/100
!Insider activity 40/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 15 out of 100
Watch Synopsys, Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

R$834.58 R$34.08 Fair Value R$32.48 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.

How to read this chart

60‑month range R$34.08 – R$834.58 · fair‑value band R$22.82 – R$44.74 · the R$63.78 price screens above the R$32.48 fair value. Dashed = 300-day average. As of Sep 29, 2026.

Follow Synopsys in your weekly email

Every Wednesday you see whether Synopsys is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP.

Show more

Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; FPGA design products that are programmed to perform specific functions; synopsys technology computer-aided design (TCAD), mask synthesis, and manufacturing analytic solutions; and AI-driven EDA solutions. It also provides pre-verified and silicon-proven IP solutions, logic libraries and embedded memories, processor and security solutions, IP Offerings for the automotive market, SOC infrastructure IP, data path and building block IP, and mathematical and floating-point components. Synopsys, Inc. has a strategic collaboration with Arm Holdings plc for development of AGI CPU that provides solutions across its full-stack design portfolio including EDA, interface IP, and hardware-assisted verification (HAV). The company was incorporated in 1986 and is headquartered in Sunnyvale, California.

Stock analysis

Synopsys, Inc. (S1NP34) currently trades at R$63.78, while our model-based Fair Value estimate is R$32.48, 49.1% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of R$24.29 per share, and 0 of the 23 models we run sit above the R$63.78 price.

Bear case: the Growth DCF group reads lowest at R$12.47, and 23 of the 23 models stay below the price. Evidence for this calculation is medium.

Scenario range: R$22.82 (bear) to R$44.74 (bull), the price of R$63.78 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 29/100 (below-average quality), in the Technology sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Synopsys, Inc. reported revenue of $7.1B in FY2025 versus $4.6B in FY2022, a compound +15.2%/yr. Reported net income was $1.3B in FY2025, compounding +10.6%/yr from FY2022.

Key figures

Market cap R$413B (≈ $79.0B) · P/E ratio 95.2 · P/S ratio 18.0 · EPS (TTM) R$5.66 · Net margin 18.9% · Return on equity 3.8% · Return on assets (EBIT) 9.5% · Operating margin 10.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 90% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at −23% fair-value upside, at −49%, S1NP34 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (R$1.54 to R$34.19). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear R$22.82 Fair Value R$32.48 Bull R$44.74
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (R$5.23 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF R$8.91 R$23.33 R$54.55 69
Growth DCF R$8.55 R$24.07 R$48.14 69
5Y EBITDA Exit R$10.48 R$26.69 R$47.96 68
All 23 models by family
DCF Models
FCF DCF R$8.91 R$23.33 R$54.55 69
5Y Revenue Exit R$4.08 R$12.71 R$24.68 64
5Y EBITDA Exit R$10.48 R$26.69 R$47.96 68
5Y P/E Exit R$10.17 R$26.01 R$45.05 64
10Y Revenue Exit R$5.19 R$14.22 R$28.75 59
10Y EBITDA Exit R$9.87 R$24.81 R$49.38 61
10Y P/E Exit R$9.66 R$24.29 R$46.79 57
Earnings-Based
Graham-Dodd R$6.12 R$34.19 R$47.47 61
Lynch FV R$9.56 R$13.65 R$17.75 58
PEG = 1.0 R$9.56 R$13.65 R$17.75 55
EPV R$0.3000 R$1.54 R$2.62 64
Multiples
P/E Multiple R$18.91 R$25.22 R$31.52 63
P/S Multiple R$11.48 R$15.31 R$19.14 58
P/B Multiple R$11.48 R$15.31 R$19.14 55
EV/EBIT R$10.67 R$16.60 R$22.54 65
EV/EBITDA R$12.24 R$18.70 R$25.17 66
EV/Revenue R$1.86 R$5.72 R$9.58 49
Asset-Based
NCAV (Graham) R$9.58 R$12.83 R$19.15 54
Growth DCF
Growth DCF R$8.55 R$24.07 R$48.14 69
Rev-Margin DCF R$4.08 R$12.47 R$24.01 64
Economic Profit
Residual Income R$14.56 R$14.63 R$15.42 68
ROIC Compounder R$0.3000 R$1.54 R$2.62 63
Growth Earnings
Growth-Adj P/E R$16.66 R$23.80 R$30.94 65

Open the full fair value analysis →

Notify me when S1NP34 reaches fair value

Put S1NP34 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 29/100

Of which business quality 36 · Market factors (momentum, volatility) 32

Profitability 32
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 50
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 22
Calm price path (market factor)
Momentum 47
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 5
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+15.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.2%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−0.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.5%
Dividend (yield on the price)0.0%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 21%

S1NP34 screens overvalued: fair value 49% below the price. Compare with Microsoft Corporation →

Compare Synopsys, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Infrastructure · 357 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside −41.8% · Below median
Profitability
Return on equity (TTM) 3.8% · Below median
Return on assets 1.5% · Below median
Net margin (TTM) 8.9% · Above median
Operating margin (TTM) 10.4% · Above median
Growth and dividend
Revenue growth 41.9% · Top 25%
Balance sheet
Debt / equity 0.48× · Highest 25%

Valuation Multiplesvs Software - Infrastructure median · lower = cheaper

P/E (TTM) 95.2× · Priciest 25%
PEG 2.24× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 24
FUTURE (revenue growth)100 · sector 60
PAST (return on equity)15 · sector 23
HEALTH (low debt)76 · sector 97
DIVIDEND (yield)0 · sector 34

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Infrastructure stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Microsoft Corporation MSFT $512.90 $564.19 +10%
Palantir Technologies Inc PLTR $187.05 $42.16 −77%
Oracle Corporation ORCL $137.30 $112.26 −18%
CrowdStrike Holdings CRWD $264.75 $37.31 −86%
Fortinet, Inc FTNT $176.33 $164.68 −7%
CoreWeave, Inc CRWV $87.12 $58.32 −33%
Block, Inc XYZ $74.04 $76.95 +4%
NetApp, Inc NTAP $204.41 $157.26 −23%
Okta, Inc OKTA $202.18 $142.12 −30%
MongoDB, Inc MDB $334.68 $130.27 −61%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Synopsys, Inc. · Fair Value
R$32.48 −49%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Synopsys, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/S1NP34

Frequently asked questions

Is Synopsys, Inc. (S1NP34) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of R$32.48 versus a price of R$63.78, about −49% upside (overvalued).
What is the fair value of S1NP34?
Our model-based fair value for Synopsys, Inc. is R$32.48 (as of Sep 29, 2026), built from audited fundamentals. The current price: R$63.78.
What is the quality score of S1NP34?
Synopsys, Inc. has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Synopsys, Inc. (S1NP34)?
Our model-based price target is the fair value of R$32.48 (as of Sep 29, 2026) from 23 valuation models. Cautious scenario R$22.82, optimistic scenario R$44.74. It is a calculation from audited fundamentals, not an analyst target.
What is the Synopsys, Inc. stock forecast for 2026?
Our models put fair value at R$32.48, about −49% upside versus a price of R$63.78 (overvalued). Cautious scenario R$22.82, optimistic scenario R$44.74. The calculation is refreshed regularly with new filings.
What is the revenue of Synopsys, Inc. (S1NP34)?
Synopsys, Inc. reported trailing-twelve-month revenue of about $8.7B (latest available figure, as of Sep 29, 2026).
What is the intrinsic value of Synopsys, Inc. (S1NP34)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Synopsys, Inc. it is R$32.48 per share (as of Sep 29, 2026), against a price of R$63.78. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Synopsys, Inc. stock overvalued or undervalued in 2026?
As of Sep 29, 2026, S1NP34 trades above its calculated fair value: price R$63.78, fair value R$32.48, a gap of about −49% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of S1NP34?
No. The price is what the market pays today (R$63.78); the fair value is what the company's own numbers justify (R$32.48). For Synopsys, Inc. the two are R$31.30 per share apart. That gap is exactly why we show both numbers side by side.
How much is Synopsys, Inc. worth?
The market values Synopsys, Inc. at about R$413B (market capitalisation, as of Sep 29, 2026). Per share that is R$63.78; our models calculate a fair value of R$32.48 per share.
What do the bullish and bearish scenarios say about S1NP34?
Our models span a range for Synopsys, Inc.: cautious scenario R$22.82, base R$32.48, optimistic R$44.74 per share (as of Sep 29, 2026, price R$63.78). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of S1NP34?
Synopsys, Inc. trades at a price-to-earnings ratio of 95.2 (as of Sep 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of R$32.48 is built from several models across several years. Other multiples: PEG 2.2.
What is the PEG ratio of S1NP34?
The PEG ratio of Synopsys, Inc. is 2.24 (P/E divided by earnings growth, as of Sep 29, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Synopsys, Inc. (S1NP34)?
Balance-sheet figures for Synopsys, Inc. (as of Sep 29, 2026): return on equity 3.8%, debt of 0.48 per unit of equity. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is S1NP34 from its 52-week high?
Synopsys, Inc. trades at R$63.78, about 90% below its 52-week high of R$662.44 and 36% above the low of R$46.90 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of R$32.48 is for.
Which stocks are comparable to Synopsys, Inc.?
From the same area (Technology) we also value Microsoft Corporation, Palantir Technologies Inc, Oracle Corporation, CrowdStrike Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Synopsys, Inc. stock attractive at the current price?
The data as of Sep 29, 2026: price R$63.78, calculated fair value R$32.48 (−49%), Quality Score 29/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of S1NP34 calculated?
We run Synopsys, Inc. through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$32.48, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Synopsys, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Synopsys, Inc. (S1NP34)?
The closing price on Oct 2, 2026 was R$63.78. Our model-based fair value is R$32.48, about −49% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Synopsys, Inc. right now?
The price sits above even our optimistic bull case (R$44.74). The favourable scenario is already priced in. Weak quality (29/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (R$22.82 to R$44.74) leaves room in how you read the outcome.

Key figures of Synopsys, Inc.

How large is the market capitalisation of Synopsys, Inc. (S1NP34)?
The market capitalisation of Synopsys, Inc. is R$413B (≈ $79.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Synopsys, Inc. (S1NP34)?
The price-to-sales ratio of Synopsys, Inc. is 18.0 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Synopsys, Inc. (S1NP34)?
Earnings per share at Synopsys, Inc. are R$5.66 (price ÷ EPS = P/E 95.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Synopsys, Inc. (S1NP34)?
The net margin of Synopsys, Inc. is 18.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Synopsys, Inc. (S1NP34)?
The return on equity (ROE) of Synopsys, Inc. is 3.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Synopsys, Inc. (S1NP34)?
On an EBIT basis the return on assets of Synopsys, Inc. is 9.5% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Synopsys, Inc. (S1NP34)?
The operating margin of Synopsys, Inc. is 10.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Synopsys, Inc. (S1NP34)?
Revenue at Synopsys, Inc. is growing +41.9% versus a year earlier (3y avg +15.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Synopsys, Inc. (S1NP34)?
Earnings per share at Synopsys, Inc. are growing −96.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Synopsys, Inc. (S1NP34) generate?
The free cash flow of Synopsys, Inc. is $1.3B (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Synopsys, Inc. (S1NP34) carry?
The net debt of Synopsys, Inc. is $10.6B (fiscal year 2025, ≈ 7.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Synopsys, Inc. in the live analysis

One click puts Synopsys, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.